What is the primary purpose of this $6 billion senior secured notes issuance?

The primary purpose is to refinance existing debt. HCA Healthcare intends to use the proceeds to repay borrowings under its senior secured asset-based revolving credit facility, redeem $1.25 billion of its 4.75% senior secured notes due 2023, and for general corporate purposes, which may include redeeming other outstanding debt.

What are the key terms and maturities of the new notes issued?

HCA issued $6 billion in aggregate principal amount of senior secured notes. These include $1 billion of 3 1/8% notes due 2027, $500 million of 3 3/8% notes due 2029, $2 billion of 3 5/8% notes due 2032, $500 million of 4 3/8% notes due 2042, and $2 billion of 4 5/8% notes due 2052. Interest is payable semi-annually.

What assets secure these new notes, and under what conditions would the security be released?

The notes are secured by first-priority liens on certain assets of HCA Inc. and its subsidiary guarantors, including capital stock of subsidiaries and substantially all tangible and intangible assets, subject to permitted liens and intercreditor arrangements. The collateral and subsidiary guarantees will be released if both Moody's and S&P issue investment-grade ratings for both the notes and the corporate family rating of HCA Healthcare and its subsidiaries.

Are these notes registered with the SEC, and what is the registration rights agreement for?

The notes were not registered under the Securities Act of 1933. HCA Healthcare entered into a registration rights agreement under which it has agreed to use its best efforts to conduct an exchange offer to exchange these unregistered notes for new debt securities that are registered under the Securities Act, with substantially identical terms. This process must be completed no later than 548 days after March 9, 2022. Failure to meet these obligations may result in additional interest payments to noteholders.

HCA 8-K: Material Agreements & Financial Events

Summary

HCA Healthcare, Inc. (HCA) announced on March 9, 2022, the completion of a significant debt offering, issuing $6 billion in aggregate principal amount of senior secured notes. These notes are divided into multiple tranches with maturities ranging from 2027 to 2052 and varying interest rates. The net proceeds of approximately $5.911 billion are earmarked for repaying existing borrowings under its senior secured asset-based revolving credit facility, redeeming $1.25 billion of 4.75% senior secured notes due 2023, and for general corporate purposes, which may include redeeming other existing debt. This transaction represents a strategic refinancing effort by HCA, aimed at extending its debt maturity profile and potentially lowering its overall cost of borrowing. The new notes are secured by a first-priority lien on certain assets, which can be released under specific conditions, including the achievement of investment-grade ratings from both Moody's and S&P for both the notes and the corporate family. Investors should note the details of the collateral, guarantees, and intercreditor arrangements, which outline the priority of claims on the company's assets.

Key Highlights

1HCA Healthcare issued $6 billion in senior secured notes across five tranches with maturities from 2027 to 2052.
2The offering generated net proceeds of approximately $5.911 billion after fees and discounts.
3Proceeds will be used to repay borrowings under its revolving credit facility and redeem $1.25 billion of 4.75% senior secured notes due 2023.
4The remaining proceeds are allocated for general corporate purposes, potentially including further debt redemption.
5The new notes are secured by a first-priority lien on certain assets, with provisions for collateral release upon achieving specific investment-grade credit ratings.
6The company entered into a registration rights agreement to facilitate an exchange offer for the unregistered notes within 548 days.
7The transaction involves complex intercreditor agreements governing the priority of liens on certain assets, particularly receivables.

HCA Healthcare, Inc. 8-K Report, Material Agreement (Mar 10, 2022)

Summary

Key Highlights

Frequently Asked Questions